All Activity

“We are moving toward making Puerto Rico a leader in clinical research and opening new opportunities for our patients, researchers, healthcare professionals, and veterans.” By Jack Gorsline, Psychedelic State(s) of America In a significant move aimed at overhauling Puerto Rico’s approach to severe mental health and substance use disorders, Gov. Jenniffer González-Colón (R) signed an executive order on Tuesday designed to transform the U.S. territory into a pioneering hub for clinical research into emerging medical therapies, including the investigational use of ibogaine. Executive Order 2026-037 will create a comprehensive assessment regarding the feasibility and advisability of establishing a “Pilot Clinical Research Program for Emerging Therapies.” The program would lay the crucial groundwork for highly regulated clinical trials involving novel and historically restricted therapeutic compounds, prioritizing scientific rigor and strict adherence to both state and federal regulatory frameworks. The administration cited the island’s ongoing battle with complex mental health challenges, neurodegenerative diseases and escalating substance use disorders as the primary catalyst for the new public policy. Recognizing that existing treatments often fall short for vulnerable populations, the government is looking toward novel compounds like ibogaine—a psychoactive alkaloid being studied globally for its potential to interrupt severe opioid and substance-use addictions—as well as other emerging therapeutics, like psilocybin and MDMA. “Scientific innovation represents an opportunity to transform the future of Puerto Rico’s healthcare system,” González-Colón said during a signing ceremony at La Fortaleza, the governor’s official residence. “Our responsibility is to prepare the island to participate in the research that will define tomorrow’s treatments, always with the highest standards of scientific rigor, ethics and regulatory compliance.” “Through this Executive Order, we are moving toward making Puerto Rico a leader in clinical research and opening new opportunities for our patients, researchers, healthcare professionals, and veterans,” she added. Today, we are taking another important step toward strengthening Puerto Rico's leadership in healthcare and scientific innovation. I signed an Executive Order to expand clinical research, promote the development of controlled clinical trials, and enhance the scientific… pic.twitter.com/h1ODfLqxUQ — Jenniffer González (@Jenniffer) August 4, 2026 Under the new directive, the Puerto Rico Department of Health is tasked with leading a strategic effort to build out the scientific, regulatory and operational infrastructure required to host cutting-edge, multicenter clinical trials. The order highlights that Puerto Rico already possesses a robust foundation to support this endeavor, citing the island’s strong academic, hospital and scientific infrastructure, which includes major universities, established research centers and highly trained medical professionals. Advocacy organizations across the island, including the Colectivo Psicodélico de Puerto Rico (also known as the Puerto Rico Psychedelic Collective) heralded the executive order as a watershed moment for Puerto Rico’s psychedelic ambitions. “As a psychedelic community, we celebrate this executive order as a meaningful signal that Puerto Rico’s government is beginning to take seriously the emerging evidence base around psychedelic therapies: Dr. Juliana Millán Torres, founder of the CPPR, told Psychedelic State(s) of America. “The archipelago is catching up to a global movement, and that fills us with hope” Millán Torres added. To ensure the program adheres to the highest medical, scientific and ethical standards, the executive order mandates the creation of a specialized Scientific and Regulatory Advisory Committee housed within the Department of Health. The governor will directly appoint the committee’s members, who will be drawn from a diverse pool of government officials and subject matter experts. The advisory body will feature specialists in clinical research, public health, bioethics, pharmacology, neurology, psychiatry, psychology and regulatory affairs. These advisors will be charged with evaluating current scientific evidence surrounding emerging therapies; assessing the logistical, clinical, ethical, and financial viability of the pilot program; and identifying necessary upgrades to the island’s physical infrastructure and medical workforce training. Furthermore, the committee will be responsible for drafting a Strategic Agenda to bolster clinical research across Puerto Rico, pinpointing priority areas for scientific inquiry, and fostering collaborative research opportunities with public, private, academic and federal entities. Underpinning this clinical research initiative is Puerto Rico’s formidable $50 billion pharmaceutical legacy, which has long cemented the island as an indispensable anchor in the broader medical supply chain across the United States and both North and South America. Sustaining tens of thousands of local STEM and manufacturing jobs, the territory’s medical equipment and life sciences export sector is a global powerhouse that currently produces roughly 90 percent of the world’s pacemakers, alongside massive quantities of contact lenses, insulin pumps and glucose monitors. Puerto Rico’s robust, world-class manufacturing infrastructure provides a well-established foundation to support the administration’s ambitious pivot toward cutting-edge clinical trials and emerging therapeutics. A prominent component of the executive order is its dedicated focus on Puerto Rican military veterans. The Department of Health is explicitly instructed to coordinate with the Office of the Puerto Rico Veterans Advocate to “facilitate educational initiatives and explore potential avenues for veterans to safely participate in the clinical trials.” Any participation would be strictly governed by rigorous eligibility criteria, available scientific evidence, and necessary regulatory authorizations. The territory’s new public policy also formally references a broader federal directive to align its objectives. The order links Puerto Rico’s efforts with an executive order signed by President Donald Trump back in April, which aims to accelerate the development of innovative medical treatments for serious mental illnesses by fostering cooperation among government agencies, the private sector, and research institutions. González-Colón’s push for advanced clinical research occurs against a turbulent political backdrop in Puerto Rico following recent revelations that the Department of Justice halted a major election fraud investigation involving her 2024 campaign. According to an investigation by ProPublica, federal narcotics agents had gathered solid evidence that “Los Tiburones,” a notorious Puerto Rican prison gang, allegedly coerced addicted inmates into voting for González-Colón during the gubernatorial primary by offering narcotics in exchange for their support, while simultaneously threatening violence and withholding drugs from those who refused. To achieve the ambitious goals outlined in the executive order, the Puerto Rico Department of Health is authorized to coordinate its efforts across a wide array of state and federal bodies. The order encourages direct collaboration with university networks, hospital systems, nonprofit organizations, and crucial federal partners. The order also states that the directive does not authorize the widespread or routine clinical use of emerging psychedelic therapies, including ibogaine, psilocybin, MDMA or any other compounds currently under investigational status. Instead, the administration emphasized that the singular purpose of the directive is to fortify the scientific and institutional readiness of Puerto Rico’s healthcare system. Looking ahead, the newly established Scientific and Regulatory Advisory Committee will operate on a strict reporting timeline. The panel is required to submit initial progress reports to the Department of Health, culminating in a final report detailing its findings and recommendations. González-Colón will then review the committee’s assessment to determine appropriate administrative actions and subsequent public policy measures required to launch the pilot program. In any event, advocates on the ground aren’t slowing down anytime soon. “It’s an exciting time to continue doing the work that needs to be done in service of a shared purpose, work that will hopefully ripple out into every part of our islands.” said Millán Torres. “The momentum is here to be embraced by the public, healthcare providers, researchers, community members, and everyone contributing in the psychedelic space, as we build this future together.” This article was produced by Psychedelic State(s) of America—a nonprofit-sponsored news organization dedicated to rigorous independent psychedelic journalism. Subscribe to PSA online and Follow PSA on Instagram, LinkedIn, Twitter/X and Facebook. Learn more about PSA and donate to the PSA Media Fund here. The post Puerto Rico Governor Signs Psychedelics Executive Order appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A top aide to President Donald Trump may have close family ties to a hemp industry executive, but that has nothing to do with the White House’s push to get Congress to delay the planned federal recriminalization of hemp THC products this week, an administration official says. Meanwhile, several sources told Marijuana Moment that the president himself called a GOP senator this week to try to get him to back off a push to keep the scheduled ban on track for November. In June, White House Chief of Staff Susie Wiles’s daughter Caroline married Bret Worley, who runs MC Nutraceuticals and other hemp companies. That has led to some accusations that the administration’s advocacy on the hemp issue is intended to benefit those close to the administration. But Kush Desai, a White House spokesperson, told The New York Times for a story published on Wednesday that Worley’s hemp business interests have no connection to the president’s position on the issue. The administration’s advocacy is in “the best interest of the American people” and is aimed at helping veterans and other people who use hemp products for medical purposes. Desai added that when Wiles met with lawmakers last week to advocate for passage of a continuing resolution to keep the government funding—which includes a provision to delay the scheduled hemp ban—she did not specifically mention the issue and “has never lobbied in favor of this or any other position on hemp with Capitol Hill,” according to the Times report. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. On Sunday, leaders of the Senate Appropriations Committee released the text of a continuing resolution to extend funding for federal agencies through December 11, past the end of the current fiscal year on September 30. Included in the legislation are provisions that will also delay the planned prohibition on most hemp products until December 11—although there is a carve-out that will allow the immediately recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” “The White House supports the provision in the temporary government funding bill, which is a modest four-week delay in implementation to allow for productive conversations to continue, that also allows the current limits to go into effect for some synthetic products permanently,” a White House official told Marijuana Moment in an email. Sen. Ted Budd (R-NC) and several GOP cosponsors have filed an amendment that seeks to strip the provisions from the legislation, however, prompting pushback from the White House. “The Trump administration opposes delaying government funding as well as important conversations over the pathway forward for the SAVE America Act,” the White House spokesperson told Marijuana Moment, referring to separate legislation to mandate proof of citizenship and photo ID requirements to vote in federal elections that is also up for consideration in the Senate and that may be held up if Budd and other GOP senators insist on demanding a vote on the hemp amendment in order to allow expedited consideration of the funding legislation. Three sources with knowledge of discussions around the issue told Marijuana Moment that Trump personally called Budd in an attempt to get him to back off the push to keep the hemp ban on track for November, but a spokesperson for the senator later clarified that there was “not an explicit ask made to Sen. Budd to drop the amendment” by the president. The spokesperson said that the hemp issue “certainly came up” during what he described as a “very friendly” discussion between Budd and Trump that also touched on number of other topics. The White House spokesperson, meanwhile, did not directly address Marijuana Moment’s request for comment on Trump’s direct outreach to lawmakers on the hemp issue this week. Budd, for his part, told The Times that he has “made it clear to the White House and my colleagues in the Senate that any action to delay” the ban “will endanger both the wellness and safety of Americans.” Punchbowl News and NBC News both reported that White House Director of Legislative Affairs James Braid spoke about the issue during a “tense” lunch with Senate Republicans on Wednesday, committing that there would be no further extensions of the hemp ban’s effective date if the current proposal is enacted. NEW — Inside Senate GOP lunch, things got tense between WH legislative affairs chief James Braid & some R senators over the hemp issue in the CR, per multiple ppl in room Braid got especially contentious with COTTON Also: Braid committed to no more extensions on the hemp issue — Andrew Desiderio (@AndrewDesiderio) August 5, 2026 Desai, the White House spokesperson, told NBC that “President Trump has made his position on hemp and cannabis abundantly clear, most recently in a December executive order and April TRUTH Social post.” “This position builds on the President’s 2018 Farm Bill, which authorized the production of hemp, and his support for Florida Amendment 3 in 2024,” he said. “The only interest guiding the Trump administration’s decision-making is the best interest of the American people, and the Administration continues to explore a Gold Science Standard-based framework on hemp to expand treatment options for American veterans and patients.” On Tuesday, a bipartisan coalition of 35 state and territory attorneys general sent a letter calling on Congress not to reverse the hemp THC product ban, saying that lawmakers’ move to enact the forthcoming prohibition “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.” In June, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded into December, but it did not have any provisions to alter the planned hemp product ban. As such, if the Senate passes its new provision it would then still need approval by the other chamber before being sent to the president. Meanwhile, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products later this year. Until now, none of those proposals have gained traction with congressional leaders. For example, Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. A press release from the congressman’s office claimed that the White House supports the legislation, which is cosponsored by Rep. Angie Craig (D-MN), but the administration has not specifically endorsed it despite generally calling for hemp regulations and backing a prior similar amendment filed by Barr. Trump and White House officials have in recent weeks repeatedly pressed Congress to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) in June, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said in June, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” The post White House Denies That Push To Protect Hemp From Ban Is Aimed At Boosting Business Interests Of Top Trump Staffer’s Family appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“They were awake, alert, more comfortable and less agitated, and this led to significant improvement in the caregiving quality of life.” By Sarah Ladd, Kentucky Lantern New research—which Kentucky participated in as a trial site—shows a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) can help late-stage dementia patients feel less agitation. Dr. Greg Jicha, the director of clinical trials at the University of Kentucky’s Sanders-Brown Center on Aging, said this combination, given to patients all over the state who participated in trials, lowered agitation scores by eight points, a “striking” reduction. “We’ve seen a lot of Alzheimer’s research really move towards the early stages in terms of prevention, and that’s really left a huge hole in the field where we have limited options to provide quality of life, dignity and respect for those that are in the later stages of disease,” Jicha said during a Tuesday morning virtual press conference. “We have very few medications that we can use for patients that may be agitated and/or have other neuropsychiatric symptoms, and these can be quite disruptive, especially for our families in our area who choose to care for their loved one at home.” Kentucky has a medical cannabis program, approved by the legislature in 2023, which allows patients experiencing a range of chronic distress to get medical marijuana prescriptions. “Notably, however, dementia is not listed,” Jicha said. Dementia is a “major leading cause of death,” he said, and “the data that we have out there do suggest that the majority of folks that are in hospice are suffering from some sort of dementia, whether they’re in hospice for the dementia itself, or for a related condition, or just other conditions that may be unrelated, such as cancer.” “I think that it was an oversight to not include dementia specifically in our state statute,” Jicha said. Alzheimer’s disease, which falls under the umbrella of dementia, is characterized by memory loss and is incurable. Treatments exist, though, including Lecanemab (brand name Leqembi), which underwent clinical trials at the University of Kentucky. This is an antibody that targets—and in some cases, removes—amyloid plaques from the brain, and has shown some success in slowing cognitive decline. According to the Alzheimer’s Association, patients experiencing agitation who have also lost “their ability to communicate effectively” may express their feelings by throwing things, moaning or groaning, repeating phrases, pacing and more. Treating this agitation can better their quality of life—and that of their caregivers and loved ones, Jicha said. “In essence, they were awake, alert, more comfortable and less agitated, and this led to significant improvement in the caregiving quality of life that was also measured in the study as an ancillary outcome measure,” Jicha said. Because of the nature of the patient population being studied, UK researchers “went mobile,” Jicha said, and drove to participants’ homes. All participants in the study were eligible for hospice; most were cared for inside their homes and many of them were bed bound. The cannabis and THC treatment was given to patients in oil form in the mouth. “I think this is an important study for folks to understand and to hear about, and to know that we’ve not forsaken their loved ones in the later stages of disease,” Jicha said, “nor have we forsaken the family members and caregivers that take on this tremendous task of love and commitment.” This story was first published by Kentucky Lantern. The post Combining THC And CBD From Marijuana Can Improve Dementia Patients’ Quality Of Life, Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

An official in the Trump administration’s White House drug office claims that “the number one drug of addiction is marijuana”—arguing that it is important to “remember the victims of marijuana, the people who’ve died from marijuana harms.” Roneet Lev, who serves as the White House Office of National Drug Control Policy’s (ONDCP) chief medical officer, made the comments on the Drug Free America Foundation’s Pathways to Prevention podcast last month. The Trump administration drug official said that she surrounds herself with pictures of people who have “tragically died” as a result of drugs, saying she “doesn’t want them to die in vain” and uses their stories as a way to remind herself of the importance of ONDCP’s work. “At first it was the parents who’ve lost children from the oxycodone and pain medicine epidemic and then fentanyl,” Lev said. “And we also remember the victims of marijuana, the people who’ve died from marijuana harms as well—or any drug. It doesn’t matter what drug. These are all potentially preventable deaths.” The Drug Enforcement Administration (DEA), however, says that “no deaths from overdose of marijuana have been reported”—though the ONDCP medical official may have been referencing people who died as a result of car accidents involving drivers who were under the influence of cannabis, for example. In the new interview on the prohibitionist organization’s podcast, Lev also said that people who are experiencing addiction should seek treatment “no matter what drugs they’re addicted to.” “And the fact is that the number one drug of addiction is marijuana. And for the first time ever in the history of the United States, the rate of substance use disorder is over the amount of alcohol use disorder—because of marijuana,” she said. “So people are suffering in our country and our strategy acknowledges that and directs efforts toward treatment.” A new federal study released last month found that Americans are now more likely to use marijuana nearly every day than they are to drink alcohol or smoke cigarettes on a daily basis. “If people have a marijuana use disorder and they have an addiction, they should be able to stop,” Lev said. “And we should be even if there’s not a medicine for it. There’s plenty of people who stop smoking cigarettes without a medicine, right? And there are medications for nicotine use disorder, but many people are able to quit and with the guidance. And we want that ability for people who have a marijuana use.” The ONDCP official also said the federal government wants people “to make informed decisions and understand the dangers.” “For example, there are hundreds of medications that interact with marijuana,” she said. “So, if you’re using marijuana and you’re also on a blood pressure medicine or a blood thinner or on psychiatric medications, you should look it up and put we have in our prevention framework we have in there. One of the tips is to use drugs.com and put in ‘cannabis’ or ‘marijuana’ or ‘cannabidiol’ for CBD, and checking that against your medications or grandpa’s medications so you make an informed decision and then you can decide for yourself if you want these and be alerted to the potential side effect.” Lev also noted during the podcast that “people are buying marijuana or hemp products or psychedelics or whatever it is that’s in the smoke shop these days.” “None of that has gone through any type of testing and you really don’t know what you’re buying,” she said. “You can’t count on the labels being correct.” Legalization advocates say that the policy change should be accompanied by regulations mandating that products be tested and labeled for ingredients, something that isn’t possible when drugs are illegal and unregulated. What does the 2026 National Drug Control Strategy mean for #prevention? Dr. Roneet Lev of @ONDCP discusses primary prevention, coalition building, faith, recovery, and creating a drug-free America as the social norm. Tune in here: https://t.co/Z4ZcUzwtdW#P2P #ONDCP pic.twitter.com/wn8Tjy6YIa — DrugFreeAmerica (@DrugFreeAmerica) July 29, 2026 Lev—an emergency medicine and addition physician—previously linked marijuana use to suicide, advocated against a Florida legalization measure and criticized health agencies’ move to reschedule cannabis. She has also said it is an “insult” to refer to cannabis as “medical.” In one episode of her own High Truths on Drugs and Addiction podcast from June 2024, she dedicated over an hour to a discussion with prohibitionist advocates about the marijuana rescheduling process that was initiated under the Biden administration, making clear she strongly disagrees with the top federal health agency’s recommendation to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). She said that people who are accepting the scientific findings that led to the recommendation,”including some in the medical community,” are “drinking that same Kool Aid again” with marijuana as they did with prescription opioids. And she claimed that the U.S. Department of Health and Human Services (HHS) produced a flawed report on cannabis, with mistakes in “like every single sentence.” “When it comes to marijuana, the harms are right in front of our eyes—but we ignore the data and follow the industry talking points just like we did in the oxycontin days,” Lev said during the segment, which featured prominent prohibitionists such as Bertha Madras, who also previously served as an ONDCP official. The revised review process that HHS relied on to reach its Schedule III determination for marijuana posts a “threat to the entire way of approving medications and to the medical community at large,” Lev said, adding that her primary contention is the idea that cannabis possesses medical value. Cannabis is “a plant with 500 different chemicals—60 different cannabinoids—many of which have not been studied, and that includes toxins and carcinogens and other things,” she said. “I really feel sorry for the public—not just for marijuana—because if you have a 90-page document from the Health and Human Services saying, ‘this is medicine, this is safe, this is monitored’ and all the things that we see in this document, they’re false to us physicians and scientists who review this material,” Lev said. “None of the science used the high-potency products. There was no consideration to the severe mental health impacts.” “But that’s just for marijuana. What is the public supposed to think when it comes to vaccines or COVID or any other public health,” she said. “I mean, there’s a loss of trust in medicine because of this process for politics and for money.” She also cast doubts on the idea that the National Institute on Drug Abuse (NIDA) supported HHS’s findings, as was expressed in a letter attached to the federal rescheduling recommendation. Lev said she personally knows people at NIDA, the Drug Enforcement Administration (DEA) and the Centers for Disease Control and Prevention (CDC) who oppose the rescheduling proposal. Further, she disputed the claim that moving marijuana to Schedule III would increase research opportunities for the plant and its constituents, saying “that’s not true.” “I don’t have hope that, if this is [rescheduled], it’ll be better regulated, because we could look at all the states now that have quote-unquote medical cannabis, and they’re run by the cannabis industry—not by independent public health people,” Lev claimed. “And we know it’s not working, because we see all the pediatric poisoning and emergency department visits and older people who are poisoned, and that those numbers are going exponentially high. And so we’ve seen that failed process.” “I think the public has lost confidence in medicine and public health after COVID and all the vaccines—and with this, we’re going to have laws that further deteriorate public health credibility, and this is an example of that,” she said, adding that it also poses an “international threat and weakness of the United States not following international laws.” That latter comment referenced potential violations of obligations on drug scheduling under United Nations treaties to which the U.S. is a party that some claim mandate the country keep cannabis in either Schedule I or Schedule II. “The U.S. will be in conflict with international law. That makes things messy,” Lev said earlier in the episode. “We have the right to withdraw from the international treaty, but then if we don’t want to follow international law, how can we expect China and Mexico to follow the law and stop pushing fentanyl on the United States? If the U.S. withdraws from international drug treaties, how does that affect other international treaties like the ones for, say, nuclear weapons?” The Trump administration has since moved forward with implementing cannabis rescheduling. Under an order issued by U.S. Acting Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). An administrative hearing is considering broader marijuana rescheduling. On another episode of her podcast that was released in October 2024, Lev took on Amendment 3, a 2024 Florida ballot initiative that sought to legalize adult-use cannabis and that received an endorsement from President Donald Trump while he was campaigning. The measure ultimately failed to meet a steep 60 percent threshold for passage. Despite Trump’s public endorsement, Lev said she wondered if the then-candidate “really read the amendment or really understands the impact of it.” And she said she wished she could have “two minutes with President Trump, because I feel like I could convince him on that.” In the episode, Lev also dismissed the notion that legalization is smart, quipping that the campaign behind the Florida initiative—Smart & Safe Florida—is a misnomer and “it seems like you can’t always go by the names of these organizations.” “We need to learn from history,” she said. “And would we want big tobacco to be in charge of the rules and marketing and nicotine potency? Would we want Purdue Pharma to be in charge of opioid overprescribing?” And if not, why are we allowing big marijuana to control the rules and regulations on public health?” Separately, during a presentation in Missouri last year, Lev reportedly said that “it’s an insult to our profession” to call marijuana “medical.” In 2018, Lev attended an event hosted by prohibitionist group Smart Approaches to Marijuana, tweeting a photo of herself with the group’s president, Kevin Sabet, along with the phrase “Marijuana Death Diaries.” Other posts she made from the event said advocates “need to get message out about marijuana public health crisis” and that “marijuana victims” speaking there told “heart breaking stories.” In 2020 she quote-tweeted a post from Sabet about a teen whose parents say he died by suicide after taking up cannabis use, adding, “marijuana hijacks your brain.” On social media, Lev has posted extensively about cannabis laws and science, making repeated suggestions tying marijuana use to mental and physical health conditions such as schizophrenia, suicide risk, lung issues and more. The post Trump White House Drug Official Claims Marijuana Is Killing People, Calling It ‘The Number One Drug Of Addiction’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great article with excellent idea!Thank you for such a valuable article. I really appreciate for this great information.. link sbobet

The item senses brilliant to learn to read like beneficial in addition to one of a kind articles or blog posts with your internet websites. koitoto

Even nevertheless there are lots of decision methods with the purpose of lookup used for non published numbers, but you would approximating rapid stately results to you possibly will look forward to in, you possibly will necessitate with the purpose of desire particular sort of swap telephone search company. <a href="https://geotechparts.ro/">iosbet</a> [url=https://geotechparts.ro/]iosbet[/url]

The item senses brilliant to learn to read like beneficial in addition to one of a kind articles or blog posts with your internet websites. hptoto

“Folks recognize that the current state of our law is not tenable. There are basically no rules.” By Claire Michal, NC Newsline The North Carolina House of Representatives will not vote on a bill that would ban intoxicating hemp products in the state until November. That’s after hundreds of hemp advocates filled the halls of the legislative building on Tuesday—and despite strong support for the bill by law enforcement leaders. Last month, the Senate passed House Bill 328, which would ban the sale of intoxicating hemp products with more than 0.4 milligrams of THC in North Carolina. The bill would also prohibit the sale of any hemp products, like CBD, or natural kratom consumables to anyone under 21, and would outlaw the sale of xylazine and synthetic kratom. THC is the psychoactive compound in cannabis. Hemp business owners say that the low threshold allowed by the bill would amount to a ban on nearly all hemp products, crippling what advocates say has become a $4 billion industry that employs some 16,000 people in North Carolina. The House did not vote on the measure during its Tuesday session, and House Speaker Destin Hall, R-Caldwell, said it won’t get a vote until after the election in November. House members “want to make sure they’re solving the problem and not making the problem worse, or doing something with unintended consequences,” Hall said. “What I plan to do is put together a group of our members to take a look at this issue and figure out the right path forward.” Hall on hemp bill dying in the House: “We’ll continue to work on it, and I’m confident something will get done.” #ncpol pic.twitter.com/LgFDH8F1tz — Bryan Anderson (@BryanRAnderson) August 5, 2026 Marijuana itself is currently illegal in North Carolina. It’s defined as cannabis with more than 0.3 percent delta-9 THC. But there are presently no restrictions, including age limits, on other hemp products that include other types of THC compounds. In 2015, the legislature allowed the cultivation of “industrial hemp,” and then in 2018, following federal law changes, it allowed the cultivation and sale of hemp products with less than 0.3 percent delta-9 THC. This created a loophole that allowed the sale of products that contain delta-8 and delta-10, two other intoxicating THC compounds, as well as THCA, a compound that turns into delta-9 THC when burned. Law enforcement leaders say the lack of regulation has turned the state into the “Wild West” for cannabis products. They’re largely in favor of an outright ban for adults as well as children. On Tuesday, dozens of police chiefs, sheriffs and prosecutors gathered with Republican lawmakers supporting the bill. During the press conference, lawmakers and public safety officials said because North Carolina has no age limit, intoxicating hemp products are currently accessible to children. Certain products, they argue, are being marketed towards children, with brightly-colored packaging. Some even mimic popular brands of candy. “Some will say this bill will put stores out of business,” said Craven County Sheriff Chip Hughes.“I say if a business depends primarily on selling these dangerous products to our children, then that will indeed be the result.” Rep. Jimmy Dixon, R-Duplin, said lawmakers made mistakes in the past when they agreed to legalize most hemp products. He said it’s time for a reset on the issue. “We’re here today because there were several misguided Republicans in the House,” he said. “Misguided, good people, but deceived.” Meantime, hundreds of employees, owners and lobbyists for hemp stores gathered in the legislative building to urge lawmakers to vote no on H328 and consider some “common sense regulations” instead of full prohibition. Eric Stahli owns Modern Apotheca in Raleigh. His wife has Crohn’s disease and uses hemp products to manage her chronic pain. He agreed that stricter regulations are needed to keep these products out of the hands of children. But he says an outright ban isn’t the answer. “We’ve been spending the last eight years serving adults, not children, and so we’re here to make sure that our House members and the public know that there are really good actors in this industry that are doing right, and we’re here to get rid of the bad actors,” Stahli said. “There are bills like SB265 that is a regulatory framework which would establish twenty-one plus requirements, marketing restrictions towards children, and a bunch of other things including testing regulations,” Chris Karis, the owner of Carolindica said “But unfortunately, that’s not what we’re here discussing.” The bill was spurred on by a looming federal ban on intoxicating hemp products enacted in last year’s Farm Bill. It’s scheduled to go into effect in November. However in June, after hemp industry lobbyists rallied to oppose the prohibition, the Trump administration sent a letter to Congress urging them to reverse the ban. After Tuesday’s session, Hall said there’s broad agreement among House lawmakers that something needs to be done about the lack of regulation of hemp, especially when it comes to people under 21. “Folks recognize that the current state of our law is not tenable. There are basically no rules. Things being sold shouldn’t be. Things being sold to kids that shouldn’t be sold,” Hall told reporters. “The question is what to do about it.” This story was first published by NC Newsline. Photo courtesy of Mike Latimer. The post North Carolina Bill To Ban Hemp THC Products Won’t Get A House Vote Until At Least November appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

State AGs push Congress not to undo hemp recriminalization; NC gov wants legal marijuana; Combat sports officials weigh cannabis breathalyzer Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Sen. Ted Budd (R-NC) said he is filing an amendment to keep the planned federal recriminalization of hemp THC products on track for November by stripping provisions to delay it from a key spending bill on the Senate floor this week. A bipartisan coalition of 35 state and territory attorneys general sent a letter urging Congress not to delay or reverse the planned federal recriminalization of hemp THC products that is set to take effect in November. North Carolina Gov. Josh Stein (D) is calling on lawmakers to pass legislation to create a “well-regulated” legal marijuana market that “protects kids” instead of advancing a more limited bill to restrict hemp THC products that is under consideration this week. Attendees at the Association of Boxing Commissions and Combative Sports conference heard a presentation about a marijuana breathalyzer device that its manufacturer says can help boxing and MMA officials address “the challenge of balancing athlete rights, public safety and competitive integrity.” The Appellate Court of Maryland ruled that police can search a vehicle based on the smell of marijuana if the occupants are under the legal age for possessing cannabis. The multi-state marijuana business Verano is suing the New Jersey Cannabis Regulatory Commission in federal court in an attempt to overturn state rules requiring cannabis companies to sign agreements with labor unions. / FEDERAL The Substance Abuse and Mental Health Services Administration tweeted, “Your health and your baby’s health matter. If you’re pregnant, planning to become pregnant, or breastfeeding, learn the facts about marijuana, including effects on growth, brain development and breastfeeding.” Sen. Tina Smith (D-MN) sent a press release about her support for provisions in a key spending bill to delay the planned federal recriminalization of hemp THC products. The House Ethics Committee is investigating Rep. Max Miller (R-OH) over allegations of illegal drug use and other violations. The House bill to accelerate psychedelic therapy development at the Department of Defense got one new cosponsor for a total of four. / STATES Puerto Rico Gov. Jenniffer González (R) signed an executive order to boost development of emerging therapies, including psychedelics. Arkansas Gov. Sarah Huckabee Sanders (R) tweeted, “Arkansas led the fight against unregulated, dangerous, intoxicating hemp products – the type of drug you see sold at gas stations. I applaud @AGTimGriffin and other AG’s for standing up on this issue. We can’t let Congress reopen loopholes that our state has already closed.” Oklahoma’s attorney general defended his banking company providing services to medical cannabis businesses in response to attacks from his opponent during a Republican gubernatorial candidate debate. Washington, D.C. regulators blocked the sale of a medical cannabis business Minnesota regulators published guidance about marijuana packaging and labeling requirements. Vermont regulators sent a reminder that mailing marijuana is prohibited. New Jersey regulators posted tips about talking to a healthcare professional about cannabis. New York regulators touted what they said is the largest seizure of illicit cannabis in the agency’s history. The California Department of Fish & Wildlife assisted in executing a search warrant at several suspected illegal marijuana cultivation sites. Washington State regulators will consider a tribal cannabis compact on Wednesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Boston, Massachusetts Cannabis Board will meet on Wednesday. / INTERNATIONAL Israel’s Ministry of Economy is reopening an investigation into claims of Canadian companies “dumping” low-cost medical cannabis products into the country’s market. / SCIENCE & HEALTH A study found that “pre-harvest mechanical stress increases cannabinoid and terpene production in cannabis.” A study of psilocybin found a “statistically significant improvement in [major depressive disorder] symptoms but not for [borderline personality disorder] symptoms.” / ADVOCACY, OPINION & ANALYSIS The Parabola Center for Law and Policy published a study on marijuana consumer opinions. / BUSINESS Verdant Capital Partners closed its acquisition of 15 Native Roots retail dispensaries in Colorado. Innovative Industrial Properties, Inc. reported quarterly revenue of $63.3 million. RYTHM, Inc. reported quarterly revenue of $23 million. / CULTURE Former basketball player Dwayne Wade is partnering with Cann on a new cannabis beverage. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Mike Latimer. The post Senate amendment would keep hemp THC product ban on track (Newsletter: August 5, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is a fascinating read on Oregon's role in the psychedelic renaissance! It's incredible to see the progress being made in integrating these powerful natural compounds for therapeutic benefits. The potential for healing anxiety and trauma is truly inspiring. Reminds me of the simple joy of creating something perfect, like a custom sundae in Papa's Freezeria!

I appreciate that the game does not force me to create an account or log in to start playing. You can jump straight into the action with zero barriers or hassle. Wave Rider values simplicity and accessibility above all else.

128. Ancestral Trauma & Psychedelic Integration A 45-year psychedelic guide on ancestral trauma, Internal Family Systems, and why integration, not the ceremony, is the real medicine. Episode Summary Most conversations about psychedelics stay at the level of the ceremony: the dose, the visions, the breakthrough. This episode goes somewhere else. Sand Symes has spent 45 years supporting women, first as a social worker, then as what she calls a modern medicine woman, and she doesn't talk about psychedelics as a fix. She talks about them as a way back to parts of yourself that got buried decades ago and never fully addressed. In this live recording from Psychedelic Salon at Town Hall Seattle, Sand walks through Internal Family Systems, the neuroscience of fear memory, the "trauma of overdoing" that hides inside high-functioning women, and why psychedelic integration for women is the part almost everyone underestimates. If you've ever wondered what actually happens after the journey ends, this is that conversation. Key Takeaways Internal Family Systems (IFS), developed by therapist Richard Schwartz, treats the mind as made up of protector parts, exiled parts carrying old pain, and a calm core self underneath. It's a mainstream therapy model, not something invented by the psychedelic space, though psychedelics often make those parts easier to access directly. The amygdala stores fear memory and drives the fight, flight, or freeze response before conscious thought catches up. Sand's description of medicine "lulling it to sleep" tracks with established neuroscience on how old memories can be revisited without the same emotional charge. The "trauma of overdoing" doesn't look like trauma. It looks like competence: the woman managing her career, her household, her aging parents, and everyone else's emotional temperature, who gets praised the entire way for never stopping. Integration, not the ceremony itself, is where the actual change takes root. Early research on post-psychedelic neuroplasticity is strongest in animal studies so far, but the pattern across integration therapists is consistent: the days and weeks after a journey are when new behavior is easiest to install. Community and ancestral wisdom show up as recurring threads for women in this work, both as ways of processing suppression carried across generations and as safeguards against re-entering ceremony without adequate support afterward. Timestamps [00:00] Disclaimer and welcome back to the show [01:00] Why this episode kicks off a month of psychedelic-informed wisdom for people over 50 [04:00] Why the clinical science on women and psychedelics still falls short [05:00] Sand Symes takes the stage: coming out of the underground after decades [08:00] The amygdala, fear memory, and what medicine work can access [10:00] Sand's first ayahuasca journey and the start of her ancestral work [13:00] Why suppression lives differently in women's bodies [18:00] Internal Family Systems: parts, protectors, and unburdening [19:00] Three case studies: religious trauma, a two-year-old self, and a six-year-old hidden in a corner [24:00] The trauma of overdoing: competence as a cover for a nervous system that can't stop [27:00] Audience Q&A begins [29:00] What integration actually requires, and why two sessions is rarely enough [33:00] The neuroplasticity window after a journey, and what the research does and doesn't show yet [38:00] Psychedelic capitalism: is there a way to do this work right at scale [47:00] Cultural respect, finding the right teacher, and misappropriation [50:00] Three ways to prepare for ceremony and three resources for becoming a guide [53:00] Cycle timing, hormones, and where the science actually stands [55:00] Closing thoughts on integration, overdoing, and Women in the Wild Guest Sand Symes is a psychedelic guide and integration therapist who has spent 45 years supporting women, first as a social worker and now as what she calls a modern medicine woman. She has sat in over 150 ceremonies, assisted in 70, and facilitated more than 60, working primarily with psilocybin and her own ancestral Celtic lineage rather than ayahuasca, MDMA, or LSD. Follow Sand Symes: website | Instagram Resources Ask April: How Do I Find a Psychedelic Guide? — column on legal access, licensed facilitators, and the Oregon versus Colorado distinction Internal Family Systems Psychedelic Salon at Town Hall Seattle Women in the Wild | small in-person gatherings in Seattle on September 12th, October 3rd, and November 7th Follow April on Substack Visit aprilpride.com Original Substack post: https://aprilpride.substack.com/sand-symes-ancestral-trauma-psychedelic-integration Hosted by April Pride IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates Get full access to APRIL PRIDE at aprilpride.substack.com/subscribeCatch the full episode here

North Carolina’s Democratic governor is calling on the Republican-controlled legislature to legalize and regulate marijuana in a way that “protects kids” while lawmakers this week are considering a bill to restrict hemp THC products. Gov. Josh Stein (D) noted in a social media post on Monday that the House of Representatives is expected to take up legislation that “aims to eliminate the Wild West that is North Carolina’s THC market.” “The legislature should be focused on creating a safe and well-regulated adult THC market that protects kids,” he said. The governor also said that “for some reason, the bill also legalizes kratom, an opioid-like substance sometimes called gas station heroin, and fails to include any meaningful age restrictions.” Tomorrow the House is considering a bill that aims to eliminate the Wild West that is North Carolina’s THC market. For some reason, the bill also legalizes kratom, an opioid-like substance sometimes called gas station heroin, and fails to include any meaningful age restrictions.… — Governor Josh Stein (@NC_Governor) August 4, 2026 In separate comments to reporters on Tuesday, Stein suggested that the hemp restriction bill’s provision’s would not sufficiently regulate or age-gate THC products. “What’s going on out there today in the market is wrong,” he said, The Carolina Journal reported. “There are no protections for kids. There are no protections for adults who choose to use these products.” “Either it has too much THC then it says it has or has less THC than it has, and it has all kinds of bacteria in it,” the governor said. “This stuff that is bad for people.” “What we need to do is have a well-regulated THC market for adults to do whatever they want to do, where they know what they’re buying, they know the quantity and they know what the ingredients are and we need to completely protect kids,” Stein said. “That is not happening with the law today and unfortunately, that bill that the legislature is thinking about doesn’t get us there either.” “We have this in the law for alcohol and cigarettes,” he said. “Why do we make it easy for them to sell hemp and kratom to kids? There’s no reason. If they have good intention, they would have real age gating and they don’t have real age gating in this bill.” Meanwhile, the North Carolina State Bureau of Investigation and other law enforcement officials are pushing lawmakers to pass the hemp restriction bill as-is. The North Carolina State Bureau of Investigation (SBI) joined other state and local law enforcement and public safety officials today at a news conference at the General Assembly in support of House Bill 328, Regulate Hemp-Derived Consumables. The bill would prohibit anyone… pic.twitter.com/eQ06MtdDXT — NC SBI (@SBI1937) August 4, 2026 The governor has repeatedly called on lawmakers to broadly legalize and regulate cannabis, though GOP legislative leaders have been more interested in focusing on the narrower hemp issue. The bill to restrict hemp and kratom products was recently approved by the Senate now awaits potential action in the House, with expectations that it could be taken up this week. Stein said earlier this month that “we need to have a well-regulated market that puts public safety and public health at its center.” “It protects kids, and it is available for adult use—because adults are using it, and we can’t put our heads in the sand any longer,” he said. House Speaker Destin Hall (R), however, said, “I know our caucus has no interest in doing any sort of marijuana, medicinal or otherwise.” Both leaders’ comments were reported by local news outlet The Assembly, which has been tracking efforts this session to pass legislation to regulate intoxicating hemp products. A commission that Stein empaneled last year recently issued a report recommending that rather than have separate frameworks for hemp and marijuana, the state should regulate THC as a molecule. “There actually used to be a distinction in the law,” the governor said. “The two plants, naturally grown, had different THC levels. You’d smoke hemp, it would take a whole lot to get you high—and it might not. Once hemp was legalized, both growers and sellers realized you could genetically modify hemp plants and increase the level of THC.” “Cannabis is cannabis,” he said. “It doesn’t make sense to try to distinguish between two varieties of the same plant, and what we really care about is, is this product going to get you high or not? That’s why we must regulate the THC molecule.” Meanwhile, lawmakers in North Carolina have been considering legislation to legalize medical cannabis for the last several sessions—with the Senate approving several proposals and the House refusing to follow suit. North Carolina’s Senate president pro tempore recently said that lawmakers will take a more serious look at legalizing medical marijuana following the Trump administration’s move to reschedule cannabis at the federal level. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The governor-appointed cannabis commission in North Carolina issued a report in April recommending that the state move away from a criminalization-based approach to the plant and toward a system of “robust” regulations that provide for adults’ legal access to THC products. The North Carolina Advisory Council on Cannabis, which Stein convened last year, says in the new document approved in April that the current “absence of regulation for North Carolina’s intoxicating cannabis market raises numerous concerns,” noting that hemp products are readily available yet largely unregulated and that marijuana remains prohibited altogether in the state, even for medical use. “Compared to regulated marijuana frameworks in other states, this environment presents identifiable risks,” the interim report says. “While some operators voluntarily implement consumer protection protocols, these safeguards are not required under state law.” Stein, for his part, thanked the group for its “expertise, hard work, and thoughtful deliberation” in a press release and reiterated his support for legalizing marijuana. Members are tasked with developing and submitting initial recommendations on a “comprehensive cannabis policy, including any proposed legislation,” with a final report due by December 31 of this year. During his time as the state’s attorney general, Stein led a separate task force under then-Gov. Roy Cooper (D) that examined racial injustice issues and ultimately recommended decriminalizing marijuana and studying broader legalization in response to racially disparate enforcement trends. A tribe in North Carolina, the Eastern Band of Cherokee Indians, launched the state’s first marijuana dispensary in 2024—despite the protests of certain Republican congressional lawmakers. Democratic lawmakers recently filed legislation to allow voters to decide whether to legalize marijuana for personal or medical use at the ballot box this November—though Senate President Pro Tem Phil Berger (R) said the bill is unlikely to advance. Meanwhile, bipartisan North Carolina lawmakers have been stepping up the push for psychedelics reform legislation. Photo courtesy of Mike Latimer. The post North Carolina Governor Pushes Lawmakers To Create A ‘Well-Regulated’ Legal Marijuana Market Instead Of Passing A Limited Hemp Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Verano did not want any of these terms. Had it been free to do so, it would not have accepted any of them. In fact, it would have signed no [labor peace agreement] at all.” By Sophie Nieto-Muñoz, New Jersey Monitor New Jersey’s mandate that cannabis companies must sign agreements with labor unions is facing another legal challenge from one of the industry’s largest operators. Verano, which runs four ZenLeaf dispensaries in New Jersey, is suing the state’s Cannabis Regulatory Commission, arguing the state can’t force it to sign what’s called a labor peace agreement with a union. Verano’s labor peace agreements require it to remain neutral when it comes to union organizing and bar Verano from making negative statements about the union, among other things. The state’s cannabis regulation law requires cannabis companies to maintain these agreements to obtain and keep a license to sell cannabis. Verano’s lawsuit, filed Friday in federal court in New Jersey, alleges this violates the National Labor Relations Act. “Verano did not want any of these terms,” the complaint states. “Had it been free to do so, it would not have accepted any of them. In fact, it would have signed no [labor peace agreement] at all.” Verano notes in the complaint that the commission has a history of enforcing the agreement condition and will dole out civil penalties when companies don’t comply. The commission fined Curaleaf, a major competitor of Verano, $610,000 in 2025 for failing to maintain its labor peace agreement. Verano said if it loses its license, it will be forced out of business, forced to fire its workers, and “sacrifice its accumulated goodwill in the local market.” The company holds licenses for dispensaries in Elizabeth, Lawrence Township, Neptune Township and Mount Holly, plus a cultivation and processing facility in Branchburg, with a total staff of about 300. The Neptune license was up for renewal August 1, with Mount Holly’s renewal coming up in November. Verano’s labor peace agreement is with Local 360 of the United Food and Commercial Workers Union. Verano is asking a judge to declare that the labor peace mandate can’t be used as grounds to deny, suspend, revoke or refuse renewal of its licenses, and that its agreements with Local 360 are voidable, which would allow the company to walk away from the union relationship. Spokespeople for the union, which is named as a defendant in Verano’s lawsuit, and for the Cannabis Regulatory Commission did not respond to requests for comment. The commission is scheduled to meet for a public meeting on Thursday. Verano’s lawsuit relies heavily on a recent decision in Curaleaf’s legal challenge to labor peace agreements. In that case, a federal judge in May denied the Cannabis Regulatory Commission’s move to dismiss Curaleaf’s lawsuit and said labor peace agreements are preempted by federal law. Verano argued its agreements with the union should now be considered void, claiming that both sides signed them under the belief that it was required under law, that Verano only signed under “illegitimate coercion,” and that the agreement’s entire purpose—regulatory compliance—no longer exists because of the ruling in the Curaleaf case. New Jersey started requiring these agreements in 2018, when the state Department of Health began scoring cannabis license applications and awarded 30 points to companies that signed one, which effectively made the agreement a necessity. It was later written into the state’s cannabis law, which led to recreational dispensaries opening their doors in April 2022. This story was first published by New Jersey Monitor. The post Marijuana Business Sues New Jersey Officials In Federal Court Over Labor Union Requirements appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A company that makes a marijuana breath testing device is pitching its services to boxing and mixed marital arts (MMA) associations as a way to assess recent cannabis use by fighters. “Combat sports involve split-second decision making, reaction time, hand-eye coordination, balance, situational awareness and athlete safety,” Cannabix Technologies Inc. said in a press release. “Unlike traditional specimen testing that can detect cannabis use long after potential effects have subsided, breath-based THC testing is designed to focus on recent use closer to the time of competition, training or incident review.” Attendees at the Association of Boxing Commissions and Combative Sports’s annual conference in Orlando will hear a 30-minute presentation about the Cannabix device on Tuesday. The event is aimed at combat sports regulators, athletic commissioners, referees and other stakeholders involved in professional boxing, MMA and other combative sports. Cannabix describes its Marijuana Breath Test as a rapid and “non-invasive” way to detect recent use of cannabis as a growing number of jurisdictions within the U.S. and internationally enact legalization laws and as “athletic commissions and sanctioning organizations are increasingly faced with the challenge of balancing athlete rights, public safety and competitive integrity.” Rav Mlait, Cannabix’s CEO, said that “combat sports regulators and athletic commissions are looking for practical tools that improve athlete safety while addressing the realities of evolving cannabis laws.” “Engaging the Marijuana Breath Test directly with this audience allows us to reach potential end users, demonstrate the value of recent-use breath testing and advance discussions around real-world deployment,” he said. $BLOZF $BLO.CSE Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference https://t.co/FES1IuiJB1 — Cannabix (@Cannabix_BLO) August 4, 2026 Jerry Crosby, president of Omega Laboratories, Cannabix’s strategic laboratory partner, said that “the value of breath testing is that it can provide more time relevant information than traditional testing methods in settings where drug use timing matters.” “For combat sports, where athlete safety, reaction time and medical decision-making are critical, recent-use testing supported by laboratory confirmation can give regulators a more practical tool for cannabis-related evaluations,” Crosby, who will lead the presentation at the conference, said. The Ultimate Fighting Championship (UFC) removed marijuana from its banned substances list for athletes in 2023. The following year, however, UFC warned fighters competing in California to “immediately” stop using cannabis after a state athletics commission said they could face penalties under state rules for testing positive for THC over a certain limit ahead of an upcoming event. Also in 2024, officials in Nevada, where many combat sports events are held, adopted a rule change that will protect athletes from being penalized for using or possessing marijuana in compliance with state law. The post Boxing And Combat Sports Officials Consider Marijuana Breathalyzer Device For Fighters appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A bipartisan coalition of 35 state and territory attorneys general are calling on Congress not to reverse the planned federal recriminalization of hemp THC products that is scheduled to take effect in November, saying that lawmakers’ move to enact the forthcoming ban “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. There is currently an effort underway in Congress to delay the hemp product ban, which industry supports say will give them more time to convince lawmakers to enact comprehensive regulations as an alternative to prohibition. On Sunday, leaders of the Senate Appropriations Committee released the text of a continuing resolution to extend funding for federal agencies through December 11, past the end of the current fiscal year on September 30. Included in the legislation are provisions that will also delay the planned prohibition on most hemp products until December 11—although there is a carve-out that will allow the immediately recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” The new letter—led by Attorney General Tim Griffin (R), Indiana Attorney General Todd Rokita (R), Connecticut Attorney General William Tong (D), and New Mexico Attorney General Raúl Torrez (D)—urges Congress to reject “any effort to delay, repeal, suspend, or weaken” the forthcoming ban and ensure it “takes effect as enacted and remains in place thereafter.” Today I led a bipartisan letter with 34 other Attorneys General urging Congress to preserve hemp reforms enacted in 2025 and reject efforts to reopen loopholes that allowed intoxicating hemp products to enter the marketplace. The bottom line is simple: Republicans and Democrats… pic.twitter.com/E3UKdP96tq — Attorney General Tim Griffin (@AGTimGriffin) August 4, 2026 The AGs note that following Congress’s action in 2025, a number of states have reformed their own hemp laws to match the narrower federal definition of legal products. “If the loophole is reopened or the new definition is weakened or repealed, States will face renewed litigation, inconsistent enforcement, regulatory uncertainty, increased youth access to intoxicating products, and disruption of lawful businesses that have already adjusted their operations to comply with the new federal framework,” the letter says. “Equally as concerning, change at this stage would allow the return of unregulated intoxicating cannabis products that Congress appropriately chose to address.” “Many, if not most, States have already imposed greater limits than are supported by the new federal definition like (1) accounting for all THC isomers in their hemp definitions and excluding cannabis that contains a combined total amount of THC that is greater than 0.3% and (2) strict limitations on hemp products containing intoxicating cannabinoids. Other states, like Delaware, Michigan, Nebraska, New Jersey, Ohio, and North Carolina have already seen legislative movement in the last seven months seeking to better align their States’ definition of ‘hemp’ with the new federal definition in various ways or otherwise assert greater control over the hemp market. Numerous States and federal agencies have also aligned their enforcement posture with the new federal hemp definition over the last seven months.” “Broadly, these actions point to a state-level response to requests by citizens, businesses, and lawmakers to implement common-sense regulations on the largely uncontrolled hemp product market,” the attorneys general wrote in the letter, which is addressed to Republican House and Senate leaders. “The new federal definition ensures both uniformity and safety throughout the nation. If the redefinition is not maintained, it will almost guarantee that these state efforts at regulation will be thrown into chaos.” Our office is co-leading a bipartisan coalition of state attorneys general directing lawmakers in Congress to reject efforts to delay implementation of the new federal definition of hemp which closes the loophole that has fueled the nationwide sale of intoxicating THC products in… pic.twitter.com/gmHIuiPnNF — AG Todd Rokita (@AGToddRokita) August 4, 2026 They argued that cracking down on intoxicating hemp products “will not inhibit the cultivation of hemp for use in the industrial or agricultural sectors (among others), since hemp plants naturally contain low levels of intoxicating cannabinoids.” “The redefinition restores the 2018 Farm Bill’s original goal of allowing the cultivation of hemp crops for uses within American industry–separate from the cultivation or processing of marijuana,” the letter says. “We now ask that you continue your work to ensure that the American people and American businesses have access to safe, nonintoxicating hemp products.” Griffin, the Arkansas attorney general, said in a press release that “Congress was absolutely right when it acted last year and adopted a clearer, more responsible framework for hemp regulation.” “States, businesses, consumers, and regulators have spent months adapting to the impending new standard, and many states have aligned their laws accordingly,” he said. “Reopening this loophole would create confusion, invite litigation, and undermine the progress we’ve made to protect consumers.” “The bottom line is simple: Republicans and Democrats across the country agree that intoxicating hemp products shouldn’t be accessible to our kids. We urge federal lawmakers to maintain the current definition of hemp and support a consistent national approach that protects public safety.” Rokita, the Indiana attorney general, argued in a press release that “Congress should not bow to the special interests that exploited a loophole in federal law to profit from selling unregulated intoxicating THC products that have harmed communities, jeopardized public safety, and put young people at risk.” “They should stand with parents, law enforcement, and legitimate hemp farmers—not the special interests profiting from selling marijuana-like products in gas stations and convenience stores,” he said. “Reject the delay, keep your promise and let the law take effect.” Connecticut AG Tong said that “Congress made the right decision when it closed a dangerous loophole, and we should keep it closed.” “These reforms protect consumers, support businesses that follow the law, and keep intoxicating hemp-derived products out of our communities. We cannot afford to go backwards,” he said. Sen. Ted Budd (R-NC) announced on Monday that he will be filing an amendment to strip provisions out of the spending bill that aim to delay the scheduled hemp product ban. The legislative vehicle that the Senate is using to fund the government and that includes the hemp ban delay provision, H.R. 6500, cleared a procedural vote on Monday and is expected to receive a vote on final passage this week after consideration of any amendments. The Beverage Alcohol Merchants Coalition (BAMCO), which represents major alcohol retailers, is supporting the move to delay the hemp product ban—saying it provides industry supporters with more time to convince Congress to “establish a responsible federal framework for low-dose hemp-derived THC beverages.” BAMCO’s members include Total Wine & More, BevMo! by Gopuff, ABC Fine Wine & Spirits, Spec’s Wine and Spirits & Finer Foods, as well as a group of hemp product wholesalers. The group supports incorporating hemp THC drinks into the existing three-tier system for alcoholic beverages, along with new requirements for testing, labeling, marketing and taxation in tandem with flexibility for state regulations. Other alcohol industry groups such as Wine & Spirits Wholesalers of America have also backed regulating hemp products instead of prohibiting them. Last month, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded into December, but it did not have any provisions to alter the planned hemp product ban. As such, if the Senate passes its new provision it would then still need approval by the other chamber before being sent to the president. Meanwhile, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products later this year. Until now, none of those proposals have gained traction with congressional leaders. For example, Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. A press release from the congressman’s office claimed that the White House supports the legislation, which is cosponsored by Rep. Angie Craig (D-MN), but the administration has not specifically endorsed it despite generally calling for hemp regulations and backing a prior similar amendment filed by Barr. Trump and White House officials have in recent weeks repeatedly pressed Congress to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) last month, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said last month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” The Wine & Spirits Wholesalers of America (WSWA), an alcohol industry trade association issued praise for Barr’s bipartisan hemp regulation bill, but said the measure’s tax provisions require “continued discussion.” Hemp policy observers expect to see a Senate companion bill to Barr’s proposal filed soon, likely from Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN). Sheehy recently cited hemp legislation as an area where Republicans and Democrats can work together in an otherwise “hyperpartisan time.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a new poll from NuggMD found that most cannabis consumers say that state-level hemp product bans that lawmakers are enacting in line with the planned federal recriminalization move are causing them to shift their purchases toward licensed marijuana businesses. The National Restaurant Association recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The post State Attorneys General Push Congress Not To Reverse Course On Banning Hemp THC Products appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“The searches were not prohibited…because they were not based solely on the odor of cannabis. Instead, they were based on the odor of cannabis, plus the knowledge that the occupants of the vehicle were under 21 years of age. By Will Hammann, Maryland Matters An odor of marijuana is not normally sufficient cause for police to conduct a search, but it can be if police determine that the occupants of a car are minors and thus prohibited from possessing cannabis, according to a new court ruling. A three-judge panel of the Appellate Court of Maryland on Thursday upheld the convictions of two teens who were pulled over in separate stops in Worcester County in 2023 and 2024, rejecting the teens’ arguments that the subsequent searches were illegal because they relied on officers smelling cannabis. Maryland law prohibits a search based solely on an odor of cannabis. But the appeals court agreed with police the odor of cannabis is probable cause for a search if the officers determined that a vehicle’s occupants are under age 21. “Here, the searches were not prohibited…because they were not based solely on the odor of cannabis,” Judge Kathryn Graeff wrote for the court. “Instead, they were based on the odor of cannabis, plus the knowledge that the occupants of the vehicle were under 21 years of age. “Because it is unlawful for a person to possess cannabis if the person is not at least 21 years of age…the statute did not prohibit the search and require that the evidence seized be excluded,” she wrote. The ruling upheld the convictions of the teens, both of whom were found guilty of underage possession of a firearm, and one of whom was found guilty of underage possession of cannabis after the searches. Graeff wrote that prior to Thursday’s ruling, there was no reported opinion by the Appellate or Supreme Court of Maryland that addressed whether knowledge of subjects’ age allows for the use of cannabis odor as probable cause. The ruling could be appealed to the Supreme Court of Maryland, but attorneys for the teens did not immediately respond to requests for comment on the ruling or their next steps Friday. The Maryland Attorney General’s Office declined to comment. According to the opinion, Ocean City Police officers pulled over a car with four occupants, including defendant Jaylen Ahnarie Sudler, around 3 a.m. on July 21, 2023, citing an inoperable tag light on the vehicle for the stop. One officer said he smelled cannabis through the open front window. When police asked the four in the car how old they were, all said they were under 21. The officers then searched the vehicle and found the firearm that later led to Sudler’s conviction for possession. On March 24, 2024, an Ocean City Police officer stopped a vehicle about 12:45 a.m. for a broken headlight. That vehicle had three occupants, including defendant Tizonn Roemello James Trotter. The officer said he smelled cannabis, learned the occupants were under the age of 21 and then searched the vehicle. After searching the car, a small baggie of cannabis, “likely within the personal use amount allowed” for someone 21 or over, and a gun were found under the front passenger seat, where Trotter sat. The opinion noted that the court only identified the age of the driver, and ordered the other passengers out of the car to search it before identifying them, but the defendant and court’s arguments proceeded on the assumption that the police knew the occupants were under 21 before conducting their search. The appellants also argued that the General Assembly’s intent behind the law banning searches solely on a smell of cannabis “was to protect Black and Brown Marylanders from a stark and longstanding form of racial profiling,” regardless of age. They added that the intent “to protect the most vulnerable group of people, minority youth, is unequivocal.” That law was the Cannabis Reform Act, which went into effect in July 2023 and legalized recreational use of cannabis for people 21 and older. It also established the provision stating the odor of cannabis or suspicion of possessing an amount legal for personal use does not provide probable cause alone. Graeff conceded that preventing racial profiling was undoubtedly a “significant factor” behind the law. “Nevertheless, [the statute] did not limit all searches involving the odor of cannabis. Rather, it limited the ability to search only when it was based solely on the odor of cannabis,” the opinion read. The defendants also pointed to the fact that lawmakers were presented with an amendment to the Cannabis Reform Act that would have allowed a search based on cannabis odor if the driver was under age 21, but they rejected that amendment. But the state argued there are a number of other reasons that amendment could have failed, such as because it was proposed late on the final day of the 2023 legislative session or that it might have caused the bill to fail altogether. It’s possible, the court argued, that legislators thought the existing language provided for the possibility to conduct a search if vehicle occupants are underage. “Legislators could have concluded, as this Court holds here, that the plain language of the statute, as written, already permitted the police to search a vehicle based on the odor of cannabis if there is the additional fact that the occupants of the vehicle are under the age of 21 years old,” Graeff wrote. Lower courts were correct to allow the evidence from the searches to be admitted at trial, she wrote. This story was first published by Maryland Matters. The post Maryland Court Allows Police To Search Cars Based On Smell Of Marijuana If Occupants Are Underage appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I simply believed it might be a concept to publish in case other people had been having issues studying however I'm just a little uncertain basically 'm permitted to place titles as well as handles upon right here. olxtoto

Experience the thrill of being completely desired by partners who prioritize your pleasure above all. Their intuitive touch and passionate responsiveness ensure every moment is charged with erotic energy. The distinguished Tagore Garden Escorts Service offer an escape into sensuality. Let them guide you through a labyrinth of delight, leaving you breathless and completely satisfied.

A Republican senator wants to make sure that hemp THC products are federally recriminalized on time under a current plan that is set to go into effect in November. Sen. Ted Budd (R-NC) announced on Monday that he will be filing an amendment to strip provisions out of a key spending bill released by Senate leaders over the weekend that aim to delay the scheduled hemp product ban. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. On Sunday, leaders of the Senate Appropriations Committee released the text of a continuing resolution to extend funding for federal agencies through December 11, past the end of the current fiscal year on September 30. Included in the legislation are provisions that will also delay the planned prohibition on most hemp products until December 11—although there is a carve-out that will allow the immediately recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Budd said in a social media post that he will be “offering an amendment to the CR to strip out an extension of the hemp loophole to ensure unregulated, dangerous intoxicants are not sold, especially to kids.” The text of the senator’s amendment has not yet been publicly released, and it’s not clear if or when it will receive a vote on the Senate floor. Before the Senate adjourns, we must pass the SAVE America Act, confirm @POTUS's outstanding noms, & fund the govt. I'm offering an amendment to the CR to strip out an extension of the hemp loophole to ensure unregulated, dangerous intoxicants are not sold, especially to kids. — Senator Ted Budd (@SenTedBuddNC) August 3, 2026 The legislative vehicle that the Senate is using to fund the government and that includes the hemp ban delay provision, H.R. 6500, cleared a procedural vote on Monday and is expected to receive a vote on final passage this week after consideration of any amendments. Budd has previously taken a number of other actions that are hostile to cannabis reform. In December, for example, he led a letter signed by other GOP senators that urged President Donald Trump not to follow through with plans to federally reschedule marijuana, claiming it would “undermine your strong efforts to Make America Great Again and to usher in America’s next economic Golden Age.” After Trump decided to move ahead with cannabis rescheduling, Budd told Marijuana Moment the president was “poorly advised” on the marijuana issue. In January, Budd and another Republican senator filed an amendment that sought to block the Justice Department from carrying out the process of reclassifying marijuana under federal law. In April, Budd introduced a bill that would require the federal government to track the cost of hospitalization due to marijuana use. The legislation’s language is similar to two amendments Budd previously filed on the cannabis and hospitalization issue that didn’t end up being considered on the Senate floor. In 2024, Budd pressed federal, state and local officials on what steps they were taking to enforce marijuana prohibition as an Indian tribe prepared to launch recreational cannabis sales on its lands within North Carolina. Meanwhile, the Beverage Alcohol Merchants Coalition (BAMCO), which represents major alcohol retailers, is supporting the move to delay the hemp product ban—saying it provides industry supporters with more time to convince Congress to “establish a responsible federal framework for low-dose hemp-derived THC beverages.” BAMCO’s members include Total Wine & More, BevMo! by Gopuff, ABC Fine Wine & Spirits, Spec’s Wine and Spirits & Finer Foods, as well as a group of hemp product wholesalers. The group supports incorporating hemp THC drinks into the existing three-tier system for alcoholic beverages, along with new requirements for testing, labeling, marketing and taxation in tandem with flexibility for state regulations. Other alcohol industry groups such as Wine & Spirits Wholesalers of America have also backed regulating hemp products instead of prohibiting them. Last month, the House of Representatives passed its own version of a continuing resolution to keep federal agencies funded into December, but it did not have any provisions to alter the planned hemp product ban. As such, if the Senate passes its new provision it would then still need approval by the other chamber before being sent to the president. Meanwhile, a number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products later this year. Until now, none of those proposals have gained traction with congressional leaders. For example, Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. A press release from the congressman’s office claimed that the White House supports the legislation, which is cosponsored by Rep. Angie Craig (D-MN), but the administration has not specifically endorsed it despite generally calling for hemp regulations and backing a prior similar amendment filed by Barr. Trump and White House officials have in recent weeks repeatedly pressed Congress to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) last month, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said last month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” The Wine & Spirits Wholesalers of America (WSWA), an alcohol industry trade association issued praise for Barr’s bipartisan hemp regulation bill, but said the measure’s tax provisions require “continued discussion.” Hemp policy observers expect to see a Senate companion bill to Barr’s proposal filed soon, likely from Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN). Sheehy recently cited hemp legislation as an area where Republicans and Democrats can work together in an otherwise “hyperpartisan time.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a new poll from NuggMD found that most cannabis consumers say that state-level hemp product bans that lawmakers are enacting in line with the planned federal recriminalization move are causing them to shift their purchases toward licensed marijuana businesses. The National Restaurant Association recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The post GOP Senator Aims To Keep Hemp THC Product Ban On Track For November With New Amendment appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I simply believed it might be a concept to publish in case other people had been having issues studying however I'm just a little uncertain basically 'm permitted to place titles as well as handles upon right here. olxtoto resmi

New bill to color-code cannabis beverages; TX & VA hemp restriction lawsuits; MA liquor store lobby: don’t roll back marijuana legalization Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Rep. Nick LaLota (R-NY) filed a bill to require federal officials to establish a system for color coding cannabis-infused beverages and other drinks that contain alcohol, kratom-related compounds or any other intoxicating substances. Virginia hemp businesses filed a federal lawsuit seeking to block enforcement of new restrictions that will ban hemp products with more than 2 milligrams of THC while the state launches legal recreational marijuana sales—calling it “economic protectionism” for certain companies. The Beverage Alcohol Merchants Coalition, which represents major alcohol retailers, is cheering the Senate’s inclusion of provisions in a key funding bill to delay the planned federal recriminalization of hemp THC products—saying it provides more time to convince Congress to “establish a responsible federal framework for low-dose hemp-derived THC beverages.” Texas regulators are facing a federal lawsuit over newly enacted hemp product restrictions, with businesses claiming they pose an unconstitutional burden on interstate commerce. The Massachusetts Package Stores Association’s Robert Mellion argues in a new op-ed that the state should regulate marijuana businesses as stringently as it does alcohol and tobacco retailers—but not return to prohibition via a ballot initiative to roll back legalization. “Cannabis retail sales are here to stay because prohibition is a proven failure.” / FEDERAL A federal judge dismissed a lawsuit alleging that Customs and Border Protection improperly denied entry into the U.S. to employees of a Canadian cannabis company. Sen. Amy Klobuchar (D-MN) sent a press release about her support for a spending bill’s provisions to delay the federal recriminalization of hemp THC products. Rep. Andy Harris (R-MD) tweeted, “Intoxicating THC gummies are poisoning and killing our children. Congress should, and must, close the hemp loophole — not fight to keep these poisons on store shelves. This is a matter of public health and safety.” Texas Democratic U.S. Senate candidate James Talarico’s campaign highlighted his opposition to banning hemp THC products. / STATES West Virginia regulators adopted changes to medical cannabis rules, including on growers/processors and dispensaries. Washington State regulators are accepting feedback about draft fuels on financial interest agreements for cannabis retailers. Illinois regulators sent guidance about changes to medical cannabis laws. New York regulators published hemp guidance. New Jersey regulators posted tips about cannabis use for older adults. Minnesota regulators sent a newsletter with various cannabis equity updates. The Virginia Cannabis Control Authority Board of Directors will meet on September 9. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Los Angeles County, California Regional Planning Commission will hold a hearing on cannabis business zoning issues on August 26. / INTERNATIONAL Gandaki Province, Nepal’s province chief signed a bill to legalize cultivation of cannabis for medical and industrial purposes. / SCIENCE & HEALTH A study found that recreational marijuana legalization “significantly reduces the food insecurity rate.” A study highlighted “the limitations of relying solely on biological THC thresholds to infer impairment.” / ADVOCACY, OPINION & ANALYSIS The American Alternative Care Policy Network is supporting veterans-focused medical cannabis legislation in Congress. / BUSINESS A Trulieve facility is being investigated by Florida officials over environmental concerns. A Total Wine & More executive said “eventually we will have regulation, not prohibition” for hemp THC drinks. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Alcohol retailers push Congress to keep hemp THC drinks legal (Newsletter: August 4, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

HTML5 technology enables Subway Surfers to operate directly within your browser, eliminating the necessity for downloads or installations. The game is a convenient option for those who have a brief respite, as it functions seamlessly on Chromebooks, educational computers, tablets, and mobile devices.

You want to get on the track right away and start drifting. Now is the time to play Drift Boss! Use your pro drifts to get around even the tightest corners and show off your timing and driving skills!